Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)

China · Delayed Price · Currency is CNY

65.30

+0.34 (0.52%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Pharmacy Research Services	558.68M	568.60M	441.90M	-	-
Pharmacy Research Services Growth	-1.74%	28.67%	-	-	-
Clinical Trials and Bioanalytical Services	511.65M	362.39M	234.50M	-	-
Clinical Trials and Bioanalytical Services Growth	41.19%	54.54%	-	-	-
Equity Sharing	6.53M	-	-	-	-
Total	1.08B	930.98M	676.39M	-	-
Total Growth	15.67%	37.64%	-	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	1.08B	932.12M	676.61M	493.65M	347.36M
China Growth	15.70%	37.76%	37.06%	42.12%	48.74%
Total	1.08B	932.12M	676.61M	493.65M	347.36M
Total Growth	15.70%	37.76%	37.06%	42.12%	48.74%

Source: S&P Global Market Intelligence.